These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1148480)

  • 1. Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog.
    Kelly JG; Shanks RG
    Br J Pharmacol; 1975 Feb; 53(2):157-62. PubMed ID: 1148480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist.
    Irie Y; Igawa T; Hosokawa T; Saitoh Y
    Eur J Pharmacol; 1979 Feb; 53(4):351-8. PubMed ID: 33812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective metabolic effects of salbutamol in anesthetized cats.
    Lockwood RH; Sinkasaem P
    Life Sci; 1976 Feb; 18(4):405-9. PubMed ID: 1256244
    [No Abstract]   [Full Text] [Related]  

  • 4. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta1- and beta2-adrenoceptors in the inhibition of gastric acid secretion in the dog.
    Daly MJ; Long JM; Stables R
    Br J Pharmacol; 1978 Sep; 64(1):153-7. PubMed ID: 212150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of metabolic adrenoceptors.
    Loakpradit T; Lockwood R
    Br J Pharmacol; 1977 Jan; 59(1):135-40. PubMed ID: 13899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some metabolic and hormonal effects of salbutamol in man.
    Massara F; Fassio V; Camanni F; Martina V; Molinatti G
    Acta Diabetol Lat; 1976; 13(3-4):146-53. PubMed ID: 1020612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and circulatory effects of oral salbutamol in the third trimester of pregnancy in diabetic and non-diabetic women.
    Wager J; Fredholm BB; Lunell NO; Persson B
    Br J Obstet Gynaecol; 1981 Apr; 88(4):352-61. PubMed ID: 6261782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and physiological effects of adrenoceptor agonists and antagonists in the horse.
    Snow DH
    Res Vet Sci; 1979 Nov; 27(3):372-8. PubMed ID: 44381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Alterations to vasodilator effects of isoprenaline in the dog following intra-arterial infusions with isoprenaline, salbutamol and orciprenaline.
    Collier PS; Shanks RG
    Br J Pharmacol; 1976 Mar; 56(3):363P-362P. PubMed ID: 1260194
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog.
    Himori N; Taira N
    Br J Pharmacol; 1977 Sep; 61(1):9-17. PubMed ID: 21014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.
    Marlin GE; Turner P
    Br J Clin Pharmacol; 1975 Feb; 2(1):41-8. PubMed ID: 10940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation.
    Ingram GI; Jones RV; Hershgold EJ; Denson KW; Perkins JR
    Br J Haematol; 1977 Jan; 35(1):81-100. PubMed ID: 869996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
    Crane J; Burgess C; Beasley R
    Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immediate effect of a beta-adrenergic agonist (salbutamol) on carbohydrate and lipid metabolism during the third trimester of pregnancy.
    Lunell NO; Joelsson I; Larsson A; Persson B
    Acta Obstet Gynecol Scand; 1977; 56(5):475-8. PubMed ID: 602717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inotropic and chronotropic responses of the guinea pig and dog myocardium to isoprenaline and salbutamol.
    Hughson RL; Ledsome JR
    Can J Physiol Pharmacol; 1975 Apr; 53(2):231-8. PubMed ID: 236817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of (-)-isoprenaline and (+/-)-salbutamol on pepsinogen and acid secretion in the dog.
    Daly MJ; Stables R
    Br J Pharmacol; 1977 Feb; 59(2):323-5. PubMed ID: 837019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
    Smith HJ; Halliday SE; Earl DC; Stribling D
    J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoceptors mediating metabolic responses in the greyhound.
    Kelly JG; Shanks RG
    Br J Pharmacol; 1971 Feb; 41(2):389P-390P. PubMed ID: 4396705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.